
Please try another search
Name | Net % | Long % | Short % |
---|---|---|---|
Cash | 18.720 | 18.720 | 0.000 |
Shares | 82.480 | 82.480 | 0.000 |
Ratios | Value | Category Average |
---|---|---|
P/E Ratio | 25.437 | 21.978 |
Price to Book | 3.432 | 3.547 |
Price to Sales | 4.180 | 3.056 |
Price to Cash Flow | 13.924 | 11.512 |
Dividend Yield | 1.119 | 1.632 |
5 Years Earnings Growth | 3.657 | 11.269 |
Name | Net % | Category Average |
---|---|---|
Healthcare | 99.970 | 27.694 |
Technology | 0.020 | 31.956 |
Number of long holdings: 55
Number of short holdings: 1
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
BeiGene Ltd Ordinary Shares | - | 8.07 | - | - | |
Innovent Biologics | KYG4818G1010 | 7.51 | 73.15 | +1.18% | |
Jiangsu Hengrui | CNE0000014W7 | 7.05 | 53.80 | -0.15% | |
Shanghai Allist Pharmaceuticals Co | CNE100005XJ7 | 6.37 | 94.30 | -0.19% | |
Sichuan Kelun Biotech | CNE1000062J1 | 4.97 | 338.40 | +1.99% | |
Sichuan Biokin Pharmaceutical | CNE100006FN4 | 4.96 | 301.61 | +0.60% | |
WuXi AppTec | CNE1000031K4 | 4.63 | 64.00 | -0.74% | |
Kelun Pharm A | CNE100000PW7 | 3.89 | 37.47 | -0.74% | |
Sinopep Allsino Bio Pharmaceutical Co | CNE1000051X5 | 3.49 | 50.17 | +0.08% | |
Hutchison China | KYG4672N1198 | 3.23 | 225.00 | +0.45% |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
CIFM China Emerging Power Class A | 5.61B | 2.14 | -5.35 | 3.56 | ||
CIFM China Emerging Power Class H | 5.61B | 2.11 | -5.38 | - | ||
CIFM Technology Qian Yan Alloc | 2.63B | -3.45 | -7.36 | - | ||
China Intl AsiaPacific Advantage St | 2.41B | 9.44 | 5.60 | 5.21 | ||
China International China Advanced | 1.62B | 2.60 | -4.80 | 0.23 |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review